article thumbnail

From GRP to SIUU – the Evolution of FDA Guidance on Off-Label Dissemination of Scientific Information

FDA Law

Previous iterations of this guidance from 2009 and 2014 (blogged on here and here ) were known as Good Reprint Practices (GRP). The SIUU Guidance, which supersedes the 2014 Draft GRP Guidance, is not substantially different in that regard and contains similar information as to the types of disclosures previously recommended.

Clinic 64
article thumbnail

Ding Dong is the Skinny Label (Effectively) Dead?

FDA Law

Teva case, that the statutory provisions governing patent infringement, specifically induced infringement, do not address carve-outs. Especially now with the utility of the use code minimized. The catch is, as we have learned from the GSK v. Teva decision changed everything. But what is a “true carve-out?”

IT 52